These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31939728)

  • 1. Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders.
    Bicker J; Fortuna A; Alves G; Falcão A
    Curr Pharm Des; 2020; 26(5):594-619. PubMed ID: 31939728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Nose to Brain Nano Delivery for Effective Management of Migraine.
    Tanna V; Sawarkar SP; Ravikumar P
    Curr Drug Deliv; 2023; 20(2):144-157. PubMed ID: 35366772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and physiological factors influencing CNS delivery upon intranasal administration.
    Vyas TK; Tiwari SB; Amiji MM
    Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
    Du L; Chen L; Liu F; Wang W; Huang H
    Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
    Islam SU; Shehzad A; Ahmed MB; Lee YS
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal drug delivery for brain targeting.
    Vyas TK; Shahiwala A; Marathe S; Misra A
    Curr Drug Deliv; 2005 Apr; 2(2):165-75. PubMed ID: 16305417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From nose to brain: understanding transport capacity and transport rate of drugs.
    Wu H; Hu K; Jiang X
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.
    Dong J; Shang Y; Inthavong K; Chan HK; Tu J
    Pharm Res; 2017 Dec; 35(1):5. PubMed ID: 29288465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-brain barrier and nasal drug delivery to the central nervous system.
    Miyake MM; Bleier BS
    Am J Rhinol Allergy; 2015; 29(2):124-7. PubMed ID: 25785753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
    Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
    Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.